Diagnosis of tuberculosis in patients in end-stage chronic kidney disease


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

In the category of persons with secondary immunodeficiency, the number of patients with end-stage chronic kidney disease is growing annually. Tuberculosis incidence and mortality among these patients are ten times higher than those in the general population. The diagnosis of tuberculosis in patients with chronic kidney disease is extremely difficult: the manifestation of the tuberculosis process does not have a characteristic clinical and radiological pattern; etiological verification rarely reaches 50%, and the possibility of immunodiagnosis of tuberculosis has not been insufficiently investigated.

全文:

受限制的访问

作者简介

O. Gordeeva

Central Research Institute of Tuberculosis

N. Karpina

Central Research Institute of Tuberculosis

参考

  1. Тареева Е.И. (ред.) Нефрология. Руководство для врачей. 2-е изд., перераб. и доп. / М.: Медицина, 2000; 687 с.
  2. Summary reports of 2016 [Electronic resource]. Global observatory on donation and transplantation activities. Mode of access: http://www.transplant-observatory.org/ reports/
  3. Neirynck N., Vanholder R., Schepers E. et al. An update on uremic toxins // Int. Urol. Nephrol. - 2013; 45: 139-50. doi: 10.1007/s11255- 012-0258-1.
  4. Papakrivopoulou E., Booth J., Pinney J. et al. Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients // Nephron Extra. -2012; 2 (1): 48-54. doi: 10.1159/000337338.
  5. Щербань Н.А. Эндобронхиальная микрогемоциркуляция и клинико-морфофункциональная характеристика патологических процессов в бронхолегочной системе у больных хронической болезнью почек (клинико-экспериментальное исследование). Дис. д-ра мед. наук. Благовещенск, 2011; 248 с.
  6. Ates G., Yildiz T., Danis R. et al. Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region // Renal failure. - 2010; 32 (1): 91-5. doi: 10.3109/08860220903367528.
  7. Moore D., Lightstone L., Javid B. et al. High rates of tuberculosis in end-stage renal failure: the impact of international migration // Emerg. Infect. Dis. - 2002; 8 (1): 77-8. doi: 10.3201/eid0801.010017.
  8. Rao T., Ram R., Swarnalatha G. et al. Tuberculosis in haemodialysis patients: A single centre experience // Indian J. Nephrol. - 2013; 23 (5): 340-5. doi: 10.4103/09714065.116296.
  9. Christopoulos A., Diamantopoulos A., Dimopoulos P. et al. Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial // BMC Nephrology. - 2009; 10 (1): 36. doi: 10.1186/1471-2369-10-36.
  10. Unsal A., Elbis A., Taner B. et al. Tuberculosis in dialysis patients: a nine-year retrospective analysis // J. Infect. Dev. Ctries. - 2013; 7 (3): 208-13. DOI: 10.3855/ jidc.2664.
  11. Chou K., Fang H., Bai K. et al. Tuberculosis in maintenance dialysis patients // Nephron. - 2001; 88 (2): 138-43. doi: 10.1159/000045974.
  12. Munoz P., Rodriguez С., Bouza Е. Mycobacterium tuberculosis infection in recipients of solid organ transplants // Clin. Infect. Dis. - 2005; 40 (4): 581-7. doi: 10.1086/427692.
  13. Агафонова С.Г., Прокопенко Е.И. Туберкулез у больных с терминальной хронической почечной недостаточностью (Обзор литературы) // Нефрология и диализ. - 2004; 6 (2): 108-16
  14. Cavusoglu C., Cicek-Saydam C., Karasu Z. et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid organ transplant recipients // Clin. Transplant. - 2002; 16 (4): 257-61. doi: 10.1034/j.1399-0012.2002.01098.x.
  15. Reis-Santos B., Gomes T., Horta B. et al. Tuberculosis prevalence in renal transplant recipients: systematic review and meta-analysis // Brazil. J. Nephrol. - 2013; 35 (3): 206-13. doi: 10.5935/0101-2800.20130033.
  16. Canet E. Incidence et prognostic de l'infection a mycobacterium tuberculosis dans le cohort multicentrique de patients transplantesrenaux en France de 1986 a 2006: Diplomed'etat de docteur un medicine / Nantes, 2008; 67 р.
  17. Ватазин А.В., Прокопенко Е.И., Перлин Д.В. и др. Особенности диагностики туберкулеза у больных хронической почечной недостаточностью на программном гемодиализе и после трансплантации почки // Нефрология и диализ. - 1999; 1 (1): 39-44
  18. Abdelrahman M., Sinha A., Karkar A. Tuberculosis in end stage renal disease patients on hemodialysis // Hemodialysis Int. - 2006; 10 (4): 360-4. doi: 10.1111/j.1542-4758.2006.00130.x.
  19. Kayabasi H., Sit D., Kadiroglu A. et al. The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: experience of a dialysis center in southeast Turkey // Renal failure. - 2008; 30 (5): 513-9. doi: 10.1080/08860220802064721.
  20. Hussein M., Mooij J., Roujouleh H. Tuberculosis and chronic renal disease // Semin. Dial. - 2003; 16 (1): 38-44.
  21. Yang, W., Han F., Zhang X. et al. Extra-pulmonary tuberculosis infection in the dialysis patients with end stage renal diseases: case reports and literature review // Journal of Zhejiang University SCIENCE B. - 2013; 14 (1): 76-82. doi: 10.1631/jzus. B1200244.
  22. Segall L., Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy // Clin. J. Am. Soc. Nephrol. - 2010; 5 (6): 1114-22. DOI: 10.2215/ CJN.09231209.
  23. Higuita L., Nieto-Rios J., Daguer-Gonzalez S. et al. Tuberculosis in renal transplant patients: The experience of a single center in Medellin-Colombia, 2005-2013 // Brazil. J. Nephrol. - 2014; 36 (4): 512-8. doi: 10.5935/0101-2800.20140073.
  24. Usta A., Shawish T., Mishra A. et al. Living related kidney transplantation in Libya: a single center experience // Transplant. Proc. - 2008; 40: 3428-33. doi: 10.1016/j.transproceed.2008.06.063.
  25. Jebali H., Barrah S., Rais L. et al. The diagnosis of tuberculosis in dialysis patients// Saudi J. Kidney Dis. Transplant. - 2017; 28 (6): 1362-8. doi: 10.4103/13192442.220882.
  26. Lakadamyali H., Lakadamyali H., Ergun T. Thorax CT findings in symptomatic hemodialysis patients // Transplant. Proc. - 2008; 40 (1): 71-6. DOI: 10.1016/j. transproceed.2007.11.037.
  27. Федеральные клинические рекомендации по организации и проведению микробиологической и молекулярно-генетической диагностики туберкулеза / М., 2014; с. 10-8.
  28. Kane Y., Faye M., Lemrabott A. Relevance of the GeneXpert Test for the Diagnosis of TB in Chronic Hemodialysis Patients in Casamance, South of Senegal // J. Kidney. - 2016; 2: 133. doi: 10.4172/2472-1220.1000133.
  29. ATS/CDC Statement Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection // Am. J. Respir. Crit. Care Med. - 2000; 161: 1376-95.
  30. Simon H. Mycobacterial and nocardial infections in the compromised host. Clinical approach to infection in the compromised host. R.H. Rubin, L.S. Young (eds.). 2nd ed. / New York: Plenum, 1988; 221-51.
  31. Poduval R., Hammes M. Tuberculosis screening in dialysis patients - is the tuberculin test effective? // Clin. Nephrol. - 2003; 59 (6): 436-40.
  32. Прил. №4 к Приказу Минздрава России от 21.03.2003 №109 «Инструкция по применению туберкулиновых проб» (в ред. Приказа Минздравсоцразвития РФ от 29.10.2009 №855)
  33. Slogotskaya. L.V., Litvinov V., Ovsyankina E. et al. Results of QuantiFERON-TB Gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection // Paediatric Resp. Rev. - 2013; 14 (2): S65.
  34. Slogotskaya L.V., Bogorodskaya E., Sentchichina O. et al. Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children // Eur. Resp. J. - 2015; 46 (S59): РА4524.
  35. Shovkun L., Aksenova V., Kudlay D. et al. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA) // Eur. Resp. J. - 2018; 52 (Suppl. 62): PA2733.
  36. Slogotskaya L.V., Litvinov V., Kudlay D.A. et al. New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, nontuberculosis disease and latent TB infection // Eur. Resp. J. - 2012; 40 (S56): 416.
  37. Старшинова А.А., Кудлай Д.А., Довгалюк И.Ф. и др. Эффективность применения новых методов иммунодиагностики туберкулезной инфекции в Российской Федерации // Педиатрия. - 2019; 98 (4): 229-35 doi: 10.24110/0031-403X-2019-98-4-229-235
  38. Pai M., Riley L., Colford J. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review // Lancet Infect. Dis. - 2004; 4 (12): 761-76. doi: 10.1016/S1473-3099(04)01206-x.
  39. Mazurek G., Jereb J., Vernon A. et al. Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection // MMWR Recomm. Rep. - 2010; 59 (RR-5): 1-25.
  40. Inoue T., Nakamura T., Katsuma A. et al. The value of QuantiFERON® TB-Gold in the diagnosis of tuberculosis among dialysis patients // Nephrol. Dial. Transplant. - 2009; 24 (7): 2252-7.
  41. Lai C., Tan C., Liao C. et al. Diagnosis of pulmonary tuberculosis among dialysis patients by enzyme-linked immunospot assay for interferon-y // Nephrol. Dial. Transplant. - 2009; 24 (8): 2605-6. doi: 10.1093/ndt/gfp224.
  42. Ferguson T., Tangri N., Macdonald K. et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and metaanalysis // Transplantation. - 2015; 99 (5): 1084-91. doi: 10.1097/TP.0000000000000451.
  43. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management / Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
  44. Canadian Tuberculosis Committee: Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS) // Can. Commun. Dis. Rep. - 2008; 34: 1-13.
  45. National Tuberculosis Advisory Committee: Position statement on interferon-gamma release immunoassays in the detection of latent tuberculosis infection [Electronic resource]. Australian Government, Department of Health and Ageing. - Mode of access: Available at http://www.health.gov.au/internet/m-ain/pub-lishing.nsf/Content/ cdna-ntac-interferon.htm
  46. Japan Society for Tuberculosis: Guideline for the use of Quantiferon TB-2G. Committee of TB Prevention // Kekkaku. - 2013; 88 (1): 33-7.
  47. Health Protection Agency of UK: Position statement on the use of Interferon Gamma Release Assay (IGRA) tests for tuberculosis (TB) [Electronic resource] // Public Health England. - Mode of access: http://www.hpa.org.uk/web/HPA-webFile/ HPAweb_C/1214808549127
  48. Swiss Lung League: Detection of latent tuberculosis using a blood test (interferon-gamma) [Electronic resource] / Berne, Swiss Federal Office of Public Health. - Mode of access: http://www.sgpp-schweiz.ch/downloads_cms/gamma-interferontest_ bag_7_11_05.pdf
  49. Position statement on the use of the new immunological tests for the diagnosis of latent tuberculosis infection [Electronic resource] / Infections and Tuberculosis Study Groups of the Italian Hospital Pulmonology Association and the Italian Society of Respiratory Medicine // Aiponet. - Mode of access: http://www.aiponet.it/download/1617.pdf (in Italian).
  50. Committee for Practical Tuberculosis Control: Positioning of interferon gamma release assays in the diagnosis of tuberculosis [Electronic resource] // NVMM. - Mode of access: http://www.nvmm.nl/nvmm/nvmmcms.nsf/uploads/16D33316B-72BA199C12573FB0043D583/$FILE/251.101%20Plaatsbepaling-%20IGRA%20 oktoberX202007.pdf (in Dutch).
  51. French National Authority for Health: Interferon gamma release assays for the diagnosis of Tuberculosis infection [Electronic resource] // HAS. - Mode of access: http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_detec-tion_de_ linterferon-gamma.pdf (in French).
  52. National TB Advisory Committee: Guidelines on the prevention and control of tuberculosis in Ireland [Electronic resource] // HPSC. - Mode of access: http://www.hpsc. ie/hpsc/A-Z/VaccinePreventable/TuberculosisTB/Publications/-ConsultationDocuments/ File.2991.en.pdf
  53. Dridi A., Kaaroud H., Boubaker K. et al. Tuberculosis in renal transplant recipients // Transplant. Proc. - 2003; 7 (35): 2682-3. doi: 10.1016/j.transproceed.2003.08.064.
  54. Aguado J., Torre-Cisneros J., Fortun J. et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology // Clin. Infect. Dis. - 2009; 48 (9): 1276-84. doi: 10.1086/597590.
  55. Anand M., Nayyar E., Concepcion B. et al. Tuberculosis in kidney transplant recipients: a case series // World J. Transplant. - 2017; 7 (3): 213-21. doi: 10.5500/wjt. v7.i3.213.
  56. Meije Y., Piersimoni C., Torre-Cisneros J. et al. Mycobacterial infections in solid organ transplant recipients // Clin. Microbiol. Infect. - 2014; 20 (7): 89-101. doi: 10.1111/1469-0691.12641.
  57. Артюхина Л.Ю., Иванова Е.С., Фролова Н.Ф. и др. Особенности течения туберкулезной инфекции на фоне иммуносупрессии у реципиентов почки // Лечебное дело. - 2015; 1: 11-7
  58. Sundaram M., Adhikary S., John G. et al. Tuberculosis in renal transplant recipients // Indian J. Urol. - 2008; 24 (3): 396-400. doi: 10.4103/0970-1591.42625.
  59. Клинические рекомендации «Диагностика, лечение и профилактика инфекционных осложнений у пациентов с трансплантированной почкой» / М.: Научное общество нефрологов России, Ассоциация нефрологов России, 2014

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2020
##common.cookie##